Skip to main content

Advertisement

Table 2 Characterization of valvular function by transthoracic echocardiography among 174 adults receiving therapy for hyperprolactinemia

From: Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study

Valve locationValvular Thickening N (%)Valvular Regurgitation N (%)
NoneMild>MildInconclusive01234
Aortic155 (89.1)19 (10.9)0014 (8.1)154 (88.5)6 (3.5)00
Mitral157 (90.2)17 (9.8)003 (1.7)164 (94.3)6 (3.5)1 (0.6)0
Pulmonic150 (86.2)1 (0.6)023 (13.2)15 (8.6)133 (76.4)26 (14.9)00
Tricuspid174 (100.0)00012 (6.9)136 (78.2)26 (14.9)00